Related Experiment Video
Updated: May 13, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Ribonuclease binase apoptotic signature in leukemic Kasumi-1 cells
Vladimir A Mitkevich1, Olga V Kretova, Irina Yu Petrushanko
1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilova Str 32, 119991 Moscow, Russia.
Abstract:
Cytotoxic exogenous RNases triggering apoptotic response in malignant cells have potential as anticancer drugs; surprisingly, detailed characterization of the RNase-induced apoptosis has not been conducted so far. Here we show that a cytotoxic RNase from Bacillus intermedius (binase) induces extrinsic and intrinsic apoptotic pathways in leukemic Kasumi-1 cells. The experiments were performed using TaqMan Array Human Apoptosis 96-well Plate for gene expression analysis, and flow cytometry. Cytometric studies demonstrated dissipation of the mitochondrial membrane potential, opening of mitochondrial permeability transition pores, activation of caspases, increase of intracellular Ca(2+) and decrease of reactive oxygen species levels. We found that expression of 62 apoptotic genes is up-regulated, including 16 genes that are highly up-regulated, and only one gene was found to be down-regulated. The highest, 16 fold increase of the expression level was observed for TNF gene. Highly up-regulated genes also include the non-canonical NF-κB signaling pathway and inflammatory caspases 1,4. The obtained results suggest that binase induces evolutionary acquired cellular response to a microbial agent and triggers unusual apoptosis pathway.
Insights
Bacillus intermedius ribonuclease (binase) triggers both extrinsic and intrinsic apoptotic pathways in leukemia cells. This study characterizes the specific cellular responses, revealing a unique apoptosis pathway potentially useful for cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Cytotoxic ribonucleases (RNases) show promise as anticancer agents by inducing apoptosis in malignant cells.
- The precise mechanisms of RNase-induced apoptosis, particularly the extrinsic and intrinsic pathways, remain incompletely understood.
- Detailed characterization is needed to explore the therapeutic potential of exogenous RNases.
Purpose of the Study:
- To characterize the apoptotic pathways induced by Bacillus intermedius ribonuclease (binase) in Kasumi-1 leukemic cells.
- To investigate the molecular and cellular events associated with binase-induced apoptosis.
- To identify key genes and signaling pathways involved in the apoptotic response to binase.
Main Methods:
- Gene expression analysis using TaqMan Array Human Apoptosis Plate.
- Flow cytometry to assess mitochondrial membrane potential, caspase activation, intracellular calcium, and reactive oxygen species.
- Analysis of extrinsic and intrinsic apoptotic pathway activation.
Main Results:
- Binase induced both extrinsic and intrinsic apoptotic pathways in Kasumi-1 cells.
- Flow cytometry revealed mitochondrial dysfunction, caspase activation, altered intracellular Ca(2+) levels, and decreased reactive oxygen species.
- Expression analysis showed significant upregulation of 62 apoptotic genes, including TNF, NF-κB signaling pathway components, and inflammatory caspases 1 and 4.
Conclusions:
- Binase triggers a complex apoptotic response in leukemic cells, involving mitochondrial pathways and caspase activation.
- The observed gene expression changes suggest an evolutionary conserved cellular defense mechanism against microbial agents.
- Binase induces an unusual apoptosis pathway, highlighting its potential as a novel anticancer therapeutic agent.
More Related Videos
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
09:18TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents
Published on: June 2, 2016